References
- Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum. 2006;36: 88–98
- Bartels CM, Bridqes AJ. Rheumatoid vasculitis: vanishing menace or target for new treatments?. Curr Rheumatol Rep. 2010;12: 414–419
- Nishimoto N. Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol. 2006;18: 277–281
- Sumida K, Ubara Y, Takemoto F, Takaichi K. Successful treatment with humanized anti-interleukin 6 receptor antibody for multidrug-refractory and anti-tumour necrosis factor-resistant systemic rheumatoid vasculitis. Clin Exp Rheumatol. 2011;29: S133
- Ozaki Y, Tanaka A, Shimamoto K, Amuro H, Kawakami K, Son Y, Ito T, Wada T, Nomura S. A case of rheumatoid pericarditis associated with a high IL-6 titer in the pericardial fluid and tocilizumab treatment. Mod Rheumatol. 2011;21: 302–304
- Nomeir AM, Turner R, Watts E, Smith D, West G, Edmonds J. Cardiac involvement in rheumatoid arthritis. Ann Intern Med. 1973;79: 800–806.
- Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford). 2006;45(Suppl 4): iv4–iv7
- Volskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JM. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case control study. Ann Rheum Dis. 1996;55: 190–192
- Puéchal X, Miceli-Richard C, Meiiad O, Lafforque P, Marcelli C, Solau-Gervais E, Steinfeld S, Villoutreix C, Trèves R, Mariette X Club Rheumatismes et inflammation (CRI). Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis. 2008;67: 880–884
- Gabay C, Emery P, Vollenhoven R, Dikranian A, Alten R, Klearman M et al. Tocilizumab (TCZ) monotherapy is superior to adalimumab (ADA) monotherapy in reducing disease activity in patients with rheumatoid arthritis (RA): 24-week data from the phase 4 ADACTA trial. Ann Rheum Dis. 2012;71(S3): 152
- Iwamoto M, Honma S, Asano Y, Minota S. Effective and safe administration of tocilizumab to a patient with rheumatoid arthritis on haemodialysis. Rheumatol Int. 2011;31: 559–560
- Hattori Y, Ubara Y, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M et al. Tocilizumab improves cardiac disease in a hemodialysis patients with AA amyloidosis secondary to rheumatoid arthritis. Amyloid. 2012;19: 37–40
- Shikama N, Terano T, Hirai A. A case of rheumatoid pericarditis with high concentrations of interleukin-6 in pericardial fluid. Heart. 2000;83: 711–712